Molecular Analysis Identifies A Subset Of Non-small Cell Lung Cancer Patients With Differential Sensitivity To Histone Deacetylase Inhibitor (hdaci)/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (egfr-tki) Treatment

被引：0
|
作者：
Jotte, R. M. [1 ]
Witta, S. E. [2 ]
Spira, A. I. [3 ]
Neubauer, M. A. [4 ]
Konduri, K. [5 ]
Ruxer, R. L. [6 ]
Hirsch, F. R. [7 ]
机构：
[1] Rocky Mt Canc Ctr, Denver, CO USA
[2] Mt Blue Canc Care Ctr, Wheat Ridge, CO USA
[3] Virginia Canc Specialists, INOVA Thorac Oncol Program, Fairfax, VA USA
[4] Kansas City Canc Ctr, Overland Pk, KS USA
[5] Baylor Sammons Canc Ctr, Dallas, TX USA
[6] SW Ft Worth Canc Ctr, Ft Worth, TX USA
[7] Univ Colorado, Ctr Canc, Aurora, CO USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S559 / S560
页数：2
相关论文
共 50 条
  • [31] Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?
    Choi, Yong Won
    Choi, Jin-Hyuk
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (03): : 422 - 428
  • [32] Patterns of extra-cranial disease progression in epidermal growth factor receptor (EGFR) mutant metastatic non-small cell lung cancer (NSCLC) patients on a tyrosine kinase inhibitor (TKI)
    Aitken, K.
    Popat, S.
    Nutting, C.
    McDonald, F.
    LUNG CANCER, 2015, 87 : S30 - S30
  • [33] Rebiopsy of Non-Small Cell Lung Cancer Patients With Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor
    Hata, Akito
    Katakami, Nobuyuki
    Yoshioka, Hiroshige
    Takeshita, Jumpei
    Tanaka, Kosuke
    Nanjo, Shigeki
    Fujita, Shiro
    Kaji, Reiko
    Imai, Yukihiro
    Monden, Kazuya
    Matsumoto, Takeshi
    Nagata, Kazuma
    Otsuka, Kyoko
    Tachikawa, Ryo
    Tomii, Keisuke
    Kunimasa, Kei
    Iwasaku, Masahiro
    Nishiyama, Akihiro
    Ishida, Tadashi
    Nishimura, Yoshihiro
    CANCER, 2013, 119 (24) : 4325 - 4332
  • [34] Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer
    Keam, Bhumsuk
    Kim, Dong-Wan
    Park, Jin Hyun
    Lee, Jeong-Ok
    Kim, Tae Min
    Lee, Se-Hoon
    Chung, Doo Hyun
    Heo, Dae Seog
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (04) : 594 - 600
  • [35] Personalized medicine for non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib
    Hamada, Akinobu
    Sasaki, Ji-ichiro
    Saeki, Sho
    Iwamoto, Norihiro
    Inaba, Megumi
    Ushijima, Sunao
    Urata, Maki
    Kishi, Hiroto
    Fujii, Shinji
    Semba, Hiroshi
    Kai, Yuki
    Saito, Hideyuki
    CANCER RESEARCH, 2010, 70
  • [36] Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer
    Bhumsuk Keam
    Dong-Wan Kim
    Jin Hyun Park
    Jeong-Ok Lee
    Tae Min Kim
    Se-Hoon Lee
    Doo Hyun Chung
    Dae Seog Heo
    International Journal of Clinical Oncology, 2014, 19 : 594 - 600
  • [37] Uncommon mutation types of Epidermal Growth Factor Receptor (EGFR) and tyrosine kinase inhibitor response in non-small cell lung carcinoma
    Wong, Maria P.
    Lee, Victor H. F.
    Yeung, Rebecca M. W.
    Tin, Vicky P. C.
    Choy, Kit Chi
    Liu, Jing
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [38] A COMPARATIVE STUDY OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR IN TREATMENT OF PATIENTS WITH BRAIN METASTASIS FROM NON-SMALL CELL LUNG CANCER
    Zhang, L.
    Cai, L.
    Zhu, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 421 - 421
  • [39] IMPACT OF EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITOR TREATMENT IN ADVANCED NON-SMALL CELL LUNG CANCER: A META-ANALYSIS
    Lee, C. K.
    Brown, C.
    Gralla, R.
    Hirsh, V.
    Inoue, A.
    Gebski, V.
    Yang, C. J.
    ANNALS OF ONCOLOGY, 2012, 23 : 414 - 414
  • [40] Small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer
    Cascone, T
    Morelli, MP
    Ciardiello, F
    ANNALS OF ONCOLOGY, 2006, 17 : 46 - 48
12345